CH675727A5 - - Google Patents

Download PDF

Info

Publication number
CH675727A5
CH675727A5 CH5119/86A CH511986A CH675727A5 CH 675727 A5 CH675727 A5 CH 675727A5 CH 5119/86 A CH5119/86 A CH 5119/86A CH 511986 A CH511986 A CH 511986A CH 675727 A5 CH675727 A5 CH 675727A5
Authority
CH
Switzerland
Prior art keywords
cells
polypeptide
sep
proliferation
oncostatin
Prior art date
Application number
CH5119/86A
Other languages
German (de)
English (en)
Inventor
Joyce M Zarling
Mohammed Shoyab
Hans Marquardt
Marcia B Hanson
Mario N Lioubin
Thomas Joseph Brown
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of CH675727A5 publication Critical patent/CH675727A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CH5119/86A 1985-12-20 1986-12-22 CH675727A5 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US93528386A 1986-11-26 1986-11-26

Publications (1)

Publication Number Publication Date
CH675727A5 true CH675727A5 (hu) 1990-10-31

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
CH5119/86A CH675727A5 (hu) 1985-12-20 1986-12-22

Country Status (29)

Country Link
JP (1) JP2559035B2 (hu)
KR (1) KR920005920B1 (hu)
CN (1) CN1017626B (hu)
AT (1) AT400444B (hu)
AU (2) AU601168B2 (hu)
BE (1) BE905957A (hu)
CA (1) CA1340296C (hu)
CH (1) CH675727A5 (hu)
CY (1) CY1608A (hu)
DE (2) DE3643428A1 (hu)
DK (1) DK174094B1 (hu)
ES (1) ES2003180A6 (hu)
FI (1) FI91484C (hu)
FR (1) FR2597108B1 (hu)
GB (1) GB2185485B (hu)
GR (1) GR862936B (hu)
HK (1) HK65691A (hu)
HU (1) HU210694B (hu)
IE (1) IE59415B1 (hu)
IL (1) IL81017A (hu)
IT (1) IT1213428B (hu)
LU (1) LU86718A1 (hu)
NL (1) NL8603209A (hu)
NO (1) NO174556C (hu)
NZ (1) NZ218634A (hu)
OA (1) OA08494A (hu)
PT (1) PT83986B (hu)
SE (1) SE505059C2 (hu)
SG (1) SG60891G (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
IL97622A (en) * 1990-03-29 1997-06-10 Oncogen Limited Partnership Se Monoclonal antibodies that inhibit growth of kaposi's sarcoma
IL97623A (en) * 1990-03-29 1996-01-19 Bristol Myers Squibb Co Monoclonal antibodies against oncostatin M, their preparation and pharmaceutical preparations containing them
WO1992002556A1 (en) * 1990-08-02 1992-02-20 Michael Valentine Agrez Human colon cancer cell-derived fibroblast elongation factor
CZ195193A3 (en) * 1992-09-25 1994-04-13 Lilly Co Eli Modified factor-4 of blood platelets, process of its preparation and pharmaceutical preparation in which it is comprised

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
NO174556C (no) 1994-05-25
LU86718A1 (fr) 1988-07-14
ATA340686A (de) 1995-05-15
JP2559035B2 (ja) 1996-11-27
SE8605459D0 (sv) 1986-12-18
IE863345L (en) 1987-06-20
DE3645095C2 (de) 1993-11-18
HU210694B (en) 1995-06-28
GR862936B (en) 1987-10-28
FI91484B (fi) 1994-03-31
SE505059C2 (sv) 1997-06-16
ES2003180A6 (es) 1988-10-16
CN86108955A (zh) 1987-12-02
GB8629997D0 (en) 1987-01-28
JPS62236498A (ja) 1987-10-16
GB2185485B (en) 1990-07-04
CN1017626B (zh) 1992-07-29
AU6660886A (en) 1987-06-25
NO865178D0 (no) 1986-12-19
HUT43103A (en) 1987-09-28
IL81017A (en) 1993-01-14
FI865156A (fi) 1987-06-21
FI865156A0 (fi) 1986-12-17
HK65691A (en) 1991-08-23
KR870005645A (ko) 1987-07-06
IL81017A0 (en) 1987-03-31
NO174556B (no) 1994-02-14
DK615386A (da) 1987-06-21
AU6776590A (en) 1991-03-14
OA08494A (fr) 1988-07-29
DE3643428C2 (hu) 1990-08-23
SG60891G (en) 1991-08-23
PT83986A (en) 1987-01-01
KR920005920B1 (ko) 1992-07-24
DE3643428A1 (de) 1987-09-24
DK174094B1 (da) 2002-06-10
NZ218634A (en) 1991-06-25
FI91484C (fi) 1994-07-11
AU639048B2 (en) 1993-07-15
NL8603209A (nl) 1987-07-16
AT400444B (de) 1995-12-27
GB2185485A (en) 1987-07-22
PT83986B (pt) 1989-07-31
IT8622787A0 (it) 1986-12-19
CA1340296C (en) 1998-12-29
IT1213428B (it) 1989-12-20
DK615386D0 (da) 1986-12-18
BE905957A (fr) 1987-06-17
FR2597108A1 (fr) 1987-10-16
NO865178L (no) 1987-06-22
AU601168B2 (en) 1990-09-06
IE59415B1 (en) 1994-02-23
CY1608A (en) 1992-04-03
FR2597108B1 (fr) 1991-02-15
SE8605459L (sv) 1987-06-21

Similar Documents

Publication Publication Date Title
DE69028671T3 (de) Löslisches extrazellulares Fragment des menschlischen IFN-beta 2/IL-6-Rezeptors, seine Herstellung und diesen Fragment enthaltende pharmazeutische Mischung
DE69034244T2 (de) Zytotoxischer Lymphozyten-Reifefaktor 35kD Untereinheit und monoklonale Antikörper spezifisch dafür
DE3650788T2 (de) Produktion des pluripotenten Granulozyten-Koloniestimulierungsfaktors
EP0471701B2 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung
US5145676A (en) Method and agents for promoting wound healing
EP0769020B1 (de) NEUE hIL-4-MUTANTENPROTEINE ALS ANTAGONISTEN ODER PARTIELLE AGONISTEN DES HUMANEN INTERLEUKIN 4
EP0705846B1 (de) Hochmolekulare und niedermolekulare Fraktionen des von Willebrand-Faktors
CH681080A5 (hu)
EP0061141A2 (en) Chemokinesins and chemotaxins of leukocytes and inflamed tissues: natural mediator proteins for reversible promotion of random and directional locomotion (chemokinesis and chemotaxis) for accumulation of specific leukocyte types, process of their biotechnical preparation and pharmaceutical compositions
CH675727A5 (hu)
DE69626829T2 (de) Monoklonale antikörper gegen lösliche tnf-alpha rezeptoren p55 und p75 als auch gegen tnf-alpha und dessen analogen
EP0119476A2 (de) Neue Immunglobulin-produzierende Hybridzellinien, deren Verwendung und Verfahren zu deren Herstellung
EP0354934A1 (de) Neutrophilen aktivierendes polypeptid, verfahren zu dessen herstellung sowie dessen verwendung als arzneimittel und diagnostikum
EP0487613B1 (en) A megakaryocytopoietic factor
Newcom et al. High molecular weight transforming growth factor β is excreted in the urine in active nodular sclerosing Hodgkin's disease
EP0452849A1 (de) Monoklonale Antikörper gegen PP4, Verfahren zu ihrer Herstellung und ihre Verwendung
DE60209797T2 (de) Antikörper zur stimulierung der produktion von il-1ra
DE19919148A1 (de) Von Interleukin 12 abgeleitete Peptid-Homodimere und Peptid-Heterodimere
JPH03504856A (ja) がん腫瘍細胞に対する肺増殖刺激因子および肺増殖阻害因子
DD282921A5 (de) Verfahren zur herstellung monoklonaler antikoerper gegen das huellprotein gp 51 des rinderleukaemievirus
WO2001019388A1 (de) Contactinhibin enthaltendes arzneimittel sowie arzneimittel, das gegen contactinhibin gerichtete antikörper enthält